Agoracom: Small Cap Investment - Zenith Epigenetics - Re: AGM - Jan 7, 2016

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

BearDownAZ

Rank: President [?]

Points: 25003 [?]

Votes: 68 Score: 4.5 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: AGM - Jan 7, 2016 - Details

in response to

Re: AGM - Jan 7, 2016 - Details

Toinv

posted on Jan 13, 2016 10:23AM

Toniv,

I wasn't aware of this either. But a quick google search turned up this Annual Information Form from 2006 for Resverlogix and on page 8 it describes the Apsley/Resverlogix reverse takeover that occured in April 2003.